Sam Gandy
Samuel E. Gandy, is a neurologist, cell biologist, Alzheimer's disease (AD) researcher and expert in the metabolism of the sticky substance called amyloid that clogs the brain in patients with Alzheimer's. His team discovered the first drugs that could lower the formation of amyloid.As of 2020, he is Mount Sinai Professor of Alzheimer's Disease Research, professor of neurology and psychiatry, Icahn School of Medicine at Mount Sinai, director, Center for Cognitive Health and NFL Neurological Center Mount Sinai Hospital, visiting principal research fellow, South Australia Health and Medical Research Institute in Adelaide, SA, Australia, and chairman emeritus of the National Medical and Scientific Advisory Council of the Alzheimer's Association. He was also founding director, Farber Institute for the Neurosciences. Provided by Wikipedia
-
1
-
2by Noam D. Beckmann, Wei-Jye Lin, Minghui Wang, Ariella T. Cohain, Alexander W. Charney, Pei Wang, Weiping Ma, Ying-Chih Wang, Cheng Jiang, Mickael Audrain, Phillip H. Comella, Amanda K. Fakira, Siddharth P. Hariharan, Gillian M. Belbin, Kiran Girdhar, Allan I. Levey, Nicholas T. Seyfried, Eric B. Dammer, Duc Duong, James J. Lah, Jean-Vianney Haure-Mirande, Ben Shackleton, Tomas Fanutza, Robert Blitzer, Eimear Kenny, Jun Zhu, Vahram Haroutunian, Pavel Katsel, Sam Gandy, Zhidong Tu, Michelle E. Ehrlich, Bin Zhang, Stephen R. Salton, Eric E. SchadtGet full text
Published 2020
article